Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABBR2 | O75899 | 2/20 | 0.44 |
| ▸ | GABBR1 | Q9UBS5 | 2/20 | 0.44 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.42 |
| ▸ | TNKS | O95271 | 1/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.42 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.42 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17730856 | 0.91 | GABBR2 (0.41) | GABBR2GABBR1HCAR2CYP2D6CYP2C19 | |
| SCHEMBL17730855 | 0.91 | GABBR2 (0.41) | GABBR2GABBR1HCAR2CYP2D6CYP2C19 | |
| SCHEMBL9380747 | 0.89 | HCAR2 (0.42) | GABBR2GABBR1HCAR2CYP2D6CYP2C19 | |
| SCHEMBL19899231 | 0.86 | GABBR2 (0.41) | GABBR2GABBR1HCAR2CYP2D6CYP2C19 | |
| SCHEMBL7238650 | 0.86 | HCAR2 (0.44) | HCAR2CYP2D6CYP2C19HDAC3TNKS | |
| SCHEMBL3144362 | 0.86 | HCAR2 (0.44) | HCAR2CYP2D6CYP2C19HDAC3TNKS | |
| SCHEMBL7239259 | 0.86 | HCAR2 (0.44) | HCAR2CYP2D6CYP2C19HDAC3TNKS | |
| SCHEMBL17730949 | 0.81 | CYP2C19 (0.62) | HCAR2CYP2D6CYP2C19SMN1; SMN2HDAC3 | |
| SCHEMBL7374430 | 0.81 | HCAR2 (0.49) | HCAR2CYP2C19KDM4EMAPK1 | |
| SCHEMBL5744606 | 0.81 | HCAR2 (0.45) | GABBR2GABBR1HCAR2CYP2D6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12629718-B2 | Film forming method and article manufacturing method | CANON KABUSHIKI KAISHA (JP) | 2026-05-19 | — | — | US | disclosed |
| US-20260077385-A1 | FILM FORMING METHOD, CURABLE COMPOSITION, AND ARTICLE MANUFACTURING METHOD | CANON KABUSHIKI KAISHA (JP) | 2026-03-19 | — | — | US | disclosed |
| US-20260042932-A1 | COMPOSITION, PATTERN FORMING METHOD, AND ARTICLE MANUFACTURING METHOD | CANON KK (JP) | 2026-02-12 | — | — | US | disclosed |
| EP-4538019-A1 | CURABLE COMPOSITION, METHOD FOR FORMING INVERTED PATTERN, METHOD FOR FORMING FILM, AND METHOD FOR PRODUCING ARTICLE | CANON KABUSHIKI KAISHA (JP) | 2025-04-16 | — | — | EP | disclosed |
| US-20250109253-A1 | CURABLE COMPOSITION, INVERTED PATTERN FORMING METHOD, FILM FORMING METHOD, AND ARTICLE MANUFACTURING METHOD | CANON KABUSHIKI KAISHA (JP) | 2025-04-03 | — | — | US | disclosed |
| US-20250084270-A1 | CURABLE COMPOSITION, FILM FORMING METHOD AND MANUFACTURING METHOD | CANON KABUSHIKI KAISHA (JP) | 2025-03-13 | — | — | US | disclosed |
| CN-119596642-A | Curable composition, film forming method and manufacturing method | 佳能株式会社 | 2025-03-11 | — | — | CN | disclosed |
| CN-119343746-A | Curable composition, reverse pattern forming method, film forming method, and article manufacturing method | 佳能株式会社 | 2025-01-21 | — | — | CN | disclosed |
| EP-4478398-A1 | FILM FORMATION METHOD AND ARTICLE MANUFACTURING METHOD | CANON KABUSHIKI KAISHA (JP) | 2024-12-18 | — | — | EP | disclosed |
| US-20240392148-A1 | PATTERN FORMING METHOD AND ARTICLE MANUFACTURING METHOD | CANON KABUSHIKI KAISHA (JP) | 2024-11-28 | — | — | US | disclosed |
| WO-2023243484-A1 | CURABLE COMPOSITION, METHOD FOR FORMING INVERTED PATTERN, METHOD FOR FORMING FILM, AND METHOD FOR PRODUCING ARTICLE | キヤノン株式会社 | 2023-12-21 | — | — | WO | disclosed |
| WO-2023162519-A1 | PATTERN FORMING METHOD AND METHOD FOR PRODUCING ARTICLE | キヤノン株式会社 | 2023-08-31 | — | — | WO | disclosed |
| WO-2023153123-A1 | FILM FORMATION METHOD AND ARTICLE MANUFACTURING METHOD | キヤノン株式会社 | 2023-08-17 | — | — | WO | disclosed |
| WO-2023112512-A1 | FILM FORMING METHOD AND METHOD FOR PRODUCING ARTICLE | キヤノン株式会社 | 2023-06-22 | — | — | WO | disclosed |
| CN-106574007-B | Photocurable composition, method for producing pattern of cured product using same, method for producing optical component, and method for producing circuit board | 佳能株式会社 | 2023-04-14 | — | — | CN | disclosed |
| WO-2022259748-A1 | CURABLE COMPOSITION, FILM FORMATION METHOD, AND ARTICLE MANUFACTURING METHOD | キヤノン株式会社 | 2022-12-15 | — | — | WO | disclosed |
| EP-3172247-B1 | PHOTOCURABLE COMPOSITION, METHOD FOR PRODUCING CURED PRODUCT PATTERN USING THE SAME, METHOD FOR PRODUCING OPTICAL COMPONENT, AND METHOD FOR PRODUCING CIRCUIT BOARD | CANON KK (JP) | 2022-03-30 | — | — | EP | disclosed |
| US-20170210837-A1 | PHOTOCURABLE COMPOSITION, METHOD FOR PRODUCING CURED PRODUCT PATTERN USING THE SAME, METHOD FOR PRODUCING OPTICAL COMPONENT, AND METHOD FOR PRODUCING CIRCUIT BOARD | CANON KABUSHIKI KAISHA (JP) | 2017-07-27 | — | — | US | disclosed |
| EP-3172247-A1 | PHOTOCURABLE COMPOSITION, METHOD FOR PRODUCING CURED PRODUCT PATTERN USING THE SAME, METHOD FOR PRODUCING OPTICAL COMPONENT, AND METHOD FOR PRODUCING CIRCUIT BOARD | Canon Kabushiki Kaisha (JP) | 2017-05-31 | — | — | EP | disclosed |
| WO-2016013216-A1 | PHOTOCURABLE COMPOSITION, METHOD FOR PRODUCING CURED PRODUCT PATTERN USING THE SAME, METHOD FOR PRODUCING OPTICAL COMPONENT, AND METHOD FOR PRODUCING CIRCUIT BOARD | CANON KABUSHIKI KAISHA (JP) | 2016-01-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260077385-A1 | FILM FORMING METHOD, CURABLE COMPOSITION, AND ARTICLE MANUFACTURING METHOD | EEF1D, RHOA, YWHAH | GABBR2 3023/4885GABBR1 2829/4885HCAR2 4824/4885 |
| US-20260042932-A1 | COMPOSITION, PATTERN FORMING METHOD, AND ARTICLE MANUFACTURING METHOD | SMCHD1, PIM1, PIM2 | GABBR2 4003/4885GABBR1 4111/4885HCAR2 4882/4885 |
| US-12629718-B2 | Film forming method and article manufacturing method | AUP1, VCL, RHOA | GABBR2 2387/4885GABBR1 2048/4885HCAR2 4831/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.